THE LOS ANGELES THORACIC & CARDIOVASCULAR FOUNDATION (EIN 956060177) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1961

Legal Domicile

Principal Officer

GREGORY L KAY

Phone

8187463073

Tax Period

2023-12-01 to 2024-03-22

THE LOS ANGELES THORACIC & CARDIOVASCULAR FOUNDATION, founded in 1961, is a micro nonprofit that reported $14K in total revenue in fiscal year 2023. Revenue fell 87% from the prior year — a significant decline worth monitoring. Expenses of $994K exceeded revenue, resulting in a 7176% operating deficit.

Mission

THE GOALS OF THIS FOUNDATION ARE TO COLLECT AND DISTRIBUTE FUNDS TO SUPPORT RESEARCH FOR THE PREVENTION, CAUSE, AND TREATMENT OF THORACIC AND CARDIOVASCULAR DISEASES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $13,660

Other Revenue $0

TOTAL REVENUE $13,660

Expense Breakdown

Grants Paid $987,989

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $5,914

TOTAL EXPENSES $993,903

Year-over-Year Comparison

	2023	2022	Change
Revenue	$13,660	$108,940	-0.9%
Expenses	$993,903	$19,853	+49.1%
Net Income	$-980,243	$89,087	-12.0%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RICARDO T BACA	TRUSTEE/TREASURER	0.1	Officer Director	$0	$0	$0
ALEXANDER FRIED ESQ	SECRETARY	0.5	Officer	$0	$0	$0
GREGORY L KAY MD	PRESIDENT	5.0	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$13,660	$993,903	No data	$-980,243
2023	$108,940	$19,853	$980,243	$89,087
2022	$834,569	$79,277	$891,156	$755,292
2021	$15	$-2,768	$135,864	$2,783
2020	$400,026	$411,125	$133,081	$-11,099
2019	$400,479	$323,500	$144,180	$76,979
2018	$329,374	$294,271	$67,201	$35,103

THE LOS ANGELES THORACIC & CARDIOVASCULAR FOUNDATION